2416. Deputy Robert O'Donoghue asked the Minister for Health if she will review the current HSE funding criteria for access to the weight management medication saxenda, in cases where it has been prescribed for clinically significant health reasons ; if she will consider allowing more compassionate and flexible discretion in individual cases, particularly where patients with serious chronic conditions such as COPD, asthma, and a history of cancer have demonstrated clear medical benefit from the treatment; and if she will make a statement on the matter. [20758/25]

Summary

2416. Deputy Robert O'Donoghue asked the Minister for Health if she will review the current HSE funding criteria for access to the weight management medication saxenda, in cases where it has been prescribed for clinically significant health reasons ; if she will consider allowing more compassionate and flexible discretion in individual cases, particularly where patients with serious chronic conditions such as COPD, asthma, and a history of cancer have demonstrated clear medical benefit from the treatment; and if she will make a statement on the matter. [20758/25]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 29 April 2025

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.